Intellectual property licensing of therapeutics during the COVID-19 crisis: lessons learnt for pandemic preparedness and response
4 July 2024
MPP’s paper: “Intellectual Property Licensing of Therapeutics During the COVID-19 Crisis: Lessons Learnt for Pandemic Preparedness and Response” was published in Globalization and Health.
Authored by MPP colleagues Tiwadayo Braimoh, Esteban Burrone, Charles Gore and MPP board member Pushpa Vijayaraghavan, this paper highlights the role of voluntary licensing in facilitating access to COVID-19 therapeutics in low- and middle-income countries. It underscores the importance of early licensing, the sharing of know-how and the quick provision of critical inputs, the efficiency of quality assurance mechanisms, local/regional manufacturing, non-exclusive agreements, among other recommendations.
The full paper can be accessed here for a comprehensive understanding of the lessons learnt and recommendations for preparedness and response to future pandemics.
